Effenberger, Maria

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 518

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease

Mayr, L., Grabherr, F., Schwärzler, J., Reitmeier, I., Sommer, F., Gehmacher, T., Niederreiter, L., He, G.-W., Ruder, B., Kunz, K. T. R., et al. (2020) · Nature Communications

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 292

Association of the COVID-19 pandemic with internet search volumes: a Google Trends™ analysis

Effenberger, M., Kronbichler, A., Shin, J. I., Mayer, G., Tilg, H., & Perco, P. (2020) · International Journal of Infectious Diseases

Data-Driven Disease SurveillanceCOVID-19 epidemiological studies

Cited by 270

Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study

Zollner, A., Schmiderer, A., Reider, S. J., Oberhuber, G., Pfister, A., Texler, B., Watschinger, C., Koch, R., Effenberger, M., Raine, T., et al. (2021) · Journal of Crohn's and Colitis

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 95

A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?

Tilg, H., Effenberger, M., & Adolph, T. E. (2020) · Expert Opinion on Investigational Drugs

Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic Diseases

Cited by 28